<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title><![CDATA[ Columns RSS Feed]]></title>
        <link>https://www.pharma-iq.com/rss/columns</link>
        <description><![CDATA[ Pharma IQ is the leading online resource hub for the global pharmaceutical professionals who have exclusive access to a library of resources including news, trends, reports, whitepapers, videos, webinars and more. ]]></description>
        <language>en</language>
        <pubDate>Sat, 02 May 2026 14:35:55 +0000</pubDate>
        <atom:link href="https://www.pharma-iq.com/rss/columns" rel="self" type="application/rss+xml"/>
                    <item>
                <title><![CDATA[What Are the Next Game Changing Drugs in Cancer Therapy?]]></title>
                <link>https://www.pharma-iq.com/pre-clinical-discovery-and-development/columns/what-are-the-next-game-changing-drugs-in-cancer?utm_medium=RSS</link>
                <description><![CDATA[ Immuno-oncology (IO) is the buzz word today and it has everyone doing IO research. Why are&nbsp;IO therapies buzzing today? If we look back at the history of cancer treatment, the survival rate&nbsp;w... ]]></description>
                <author><![CDATA[  (Regina Au) ]]></author>
                <guid>https://www.pharma-iq.com/pre-clinical-discovery-and-development/columns/what-are-the-next-game-changing-drugs-in-cancer?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:26 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[George Clinical harnessing innovation to improve patient retention in clinical t...]]></title>
                <link>https://www.pharma-iq.com/clinical/columns/george-clinical-harnessing-innovation-to-improve?utm_medium=RSS</link>
                <description><![CDATA[ George Clinical’s parent organisation, The George Institute for Global Health and its TEXTCARE application, has been named a top 10 finalist in this year’s&nbsp;Google Impact Challenge. With a top pri... ]]></description>
                <author><![CDATA[  (Pharmaceuticals &amp; Biotechnology Editor) ]]></author>
                <guid>https://www.pharma-iq.com/clinical/columns/george-clinical-harnessing-innovation-to-improve?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:26 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[ EDC Platform Investment Is Critical To A CRO’s Survival ]]></title>
                <link>https://www.pharma-iq.com/clinical/columns/edc-platform-investment-is-critical-to-a-cro’s?utm_medium=RSS</link>
                <description><![CDATA[ As the costs and complexities of running clinical trials increase, so does the impetus, indeed obligation, to invest in fully integrated eSystems that are essential to simplifying the overall clinical... ]]></description>
                <author><![CDATA[ Notavailable@notavailable.com (George Clinical Representative) ]]></author>
                <guid>https://www.pharma-iq.com/clinical/columns/edc-platform-investment-is-critical-to-a-cro’s?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:25 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Case Study: Scientific Leadership in complex, multi-regional trials boosts recru...]]></title>
                <link>https://www.pharma-iq.com/clinical/columns/case-study-scientific-leadership-in-complex-multi?utm_medium=RSS</link>
                <description><![CDATA[ The scientific leadership model for conducting clinical trials is relatively new. Despite its novelty, scientific leadership continues to prove its worth when comparing recruitment metrics both before... ]]></description>
                <author><![CDATA[ Notavailable@notavailable.com (George Clinical Representative) ]]></author>
                <guid>https://www.pharma-iq.com/clinical/columns/case-study-scientific-leadership-in-complex-multi?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:25 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Lessons Learned On The Road To Serialisation]]></title>
                <link>https://www.pharma-iq.com/market-access/columns/lessons-learned-on-the-road-to-serialisation?utm_medium=RSS</link>
                <description><![CDATA[ In the previous articles in this series on serialisation, we have explained the issues associated with counterfeit pharmaceutical products, the various aspects of serialisation and how you would go ab... ]]></description>
                <author><![CDATA[  (Andrew Love) ]]></author>
                <guid>https://www.pharma-iq.com/market-access/columns/lessons-learned-on-the-road-to-serialisation?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Investigator networks cultivated through risk-factor trials, drives data diversi...]]></title>
                <link>https://www.pharma-iq.com/clinical/columns/investigator-networks-cultivated-through-risk?utm_medium=RSS</link>
                <description><![CDATA[ Extensive investigator networks, cultivated over the course of some of the world’s largest clinical trials into the risk factors for dementia, present an exciting opportunity for the future of dementi... ]]></description>
                <author><![CDATA[ Notavailable@notavailable.com (George Clinical Representative) ]]></author>
                <guid>https://www.pharma-iq.com/clinical/columns/investigator-networks-cultivated-through-risk?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:22 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Tips For Creating A Serialisation Strategy]]></title>
                <link>https://www.pharma-iq.com/regulatorylegal/columns/tips-for-creating-a-serialisation-strategy?utm_medium=RSS</link>
                <description><![CDATA[ In my last article I talked about the need to be responsive to an evolving picture both when selecting your implementation partners but also when working out what is going to be the best solution for... ]]></description>
                <author><![CDATA[  (Andrew Love) ]]></author>
                <guid>https://www.pharma-iq.com/regulatorylegal/columns/tips-for-creating-a-serialisation-strategy?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:21 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Selecting Implementation Partners for your Serialisation Strategy]]></title>
                <link>https://www.pharma-iq.com/market-access/columns/selecting-implementation-partners-for-your?utm_medium=RSS</link>
                <description><![CDATA[ In the last article I looked at the starting point of developing your organisation’s strategy, the legislation and its impact. In this article I discuss defining your solution, what to look for when p... ]]></description>
                <author><![CDATA[  (Andrew Love) ]]></author>
                <guid>https://www.pharma-iq.com/market-access/columns/selecting-implementation-partners-for-your?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:20 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[How 3D Printing has Influenced and Advanced Medicine]]></title>
                <link>https://www.pharma-iq.com/manufacturing/columns/how-3d-printing-has-influenced-and-advanced?utm_medium=RSS</link>
                <description><![CDATA[ &nbsp;Regenerative medicine or man-made regeneration has been influenced and advanced the most with 3D printing technology. &nbsp;Scientists using stem cells and/or various forms of scaffolding have t... ]]></description>
                <author><![CDATA[  (Regina Au) ]]></author>
                <guid>https://www.pharma-iq.com/manufacturing/columns/how-3d-printing-has-influenced-and-advanced?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[A More Balanced Understanding Of “Risk”]]></title>
                <link>https://www.pharma-iq.com/manufacturing/columns/a-more-balanced-understanding-of-“risk”?utm_medium=RSS</link>
                <description><![CDATA[ &nbsp;Earlier this year I was fortunate enough to attend the Disposable Solutions meeting in Munich. A common theme of discussions was the on-going debates around the issues of leachable and extractab... ]]></description>
                <author><![CDATA[  (Tony Hitchcock) ]]></author>
                <guid>https://www.pharma-iq.com/manufacturing/columns/a-more-balanced-understanding-of-“risk”?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:20 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Tips for your Serialisation Strategy]]></title>
                <link>https://www.pharma-iq.com/market-access/columns/tips-for-your-serialisation-strategy?utm_medium=RSS</link>
                <description><![CDATA[ Serialisation legislation will require new capabilities to be implemented across many different functions of a typical company.The most obvious include:•&nbsp;Regulatory and legislative management and... ]]></description>
                <author><![CDATA[  (Andrew Love) ]]></author>
                <guid>https://www.pharma-iq.com/market-access/columns/tips-for-your-serialisation-strategy?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:03 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[From High Tech to MedTech]]></title>
                <link>https://www.pharma-iq.com/medical-devices-and-diagnostics/columns/from-high-tech-to-medtech?utm_medium=RSS</link>
                <description><![CDATA[ In the medtech world, the boundaries between the semiconductor and medtech industries have already been blurred with chips, sensors and Micro-Electro-Mechanical Systems (MEMS). Today, the boundaries b... ]]></description>
                <author><![CDATA[  (Regina Au) ]]></author>
                <guid>https://www.pharma-iq.com/medical-devices-and-diagnostics/columns/from-high-tech-to-medtech?utm_medium=RSS</guid>
                <pubDate>Fri, 23 Aug 2024 16:00:23 +0000</pubDate>
            </item>
            </channel>
</rss>